Journal of the American Society of Hypertension
Volume 1, Issue 2 , Pages 104-112 , March 2007

Effects of pharmacological intervention on arterial stiffness using pulse wave velocity measurement

  • Roland Asmar, MD

      Affiliations

    • Corresponding Author InformationCorresponding author: Roland Asmar, MD, The Cardiovascular Institute, 2, rue du Docteur Blanche, F-75016 Paris, France. Tel: +33 1 55 74 66 66; fax: +33 1 55 74 66 65.

Received 19 January 2007 ,Accepted 19 January 2007.

References 

  1. Girerd X, Chanudet X, Larroque P, Clement R, Laloux B, Safar ME. Early arterial modifications in young patients with borderline hypertension. J Hypertens. 1989;7(suppl 1):S456–S457
  2. Amar J, Chamontin B, Pelissier M, Garelli I, Salvador M. Influence of glucose metabolism on nycthemeral blood pressure variability in hypertensives with an elevated waist-hip ratio (A link with arterial distensibility). Am J Hypertens. 1995;8:426–428
  3. Asmar R. Factors influencing pulse wave velocity. In:  Safar ME editors. Arterial Stiffness and Pulse Wave Velocity: Clinical Applications. Paris, France: Editions Scientifiques et Médicales Elsevier SAS; 1999;p. 57–86
  4. Pannier B, Avolio AP, Hoeks A, Mancia G, Takazawa K. Methods and devices for measuring arterial compliance in humans. Am J Hypertens. 2002;15:743–753
  5. Asmar R. Pulse wave velocity (Principles and measurements). In:  Safar ME editors. Arterial Stiffness and Pulse Wave Velocity: Clinical Applications. Paris, France: Editions Scientifiques et Médicales Elsevier SAS; 1999;p. 25–53
  6. Laurent S, Cockcroft J, van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, et al. European Network for Non-invasive Investigation of Large Arteries Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 2006;27:2588–2605
  7. Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM. Impact of aortic stiffness on survival in end-stage renal disease. Circulation. 1999;99:2434–2439
  8. Boutouyrie P, Tropeano AI, Asmar R, Gautier I, Benetos A, Lacolley P, et al. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension. 2002;39:10–15
  9. Cruickshank K, Riste L, Anderson SG, Wright JS, Dunn G, Gosling RG. Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function?. Circulation. 2002;106:2085–2090
  10. Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension. 2001;37:1236–1241
  11. Laurent S, Katsahian S, Fassot C, Tropeano AI, Laloux B, Boutouyrie P. Aortic stiffness is an independent predictor of fatal stroke in essential hypertension. Stroke. 2003;34:1203–1206
  12. Mattace-Raso FU, van der Cammen TJ, Hofman A, van Popele NM, Bos ML, Schalekamp MA, et al. Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. Circulation. 2006;113:657–663
  13. Meaume S, Benetos A, Henry OF, Rudnichi A, Safar ME. Aortic pulse wave velocity predicts cardiovascular mortality in subjects 70 years of age. Arterioscler Thromb Vasc Biol. 2001;21:2046–2050
  14. Sutton-Tyrrell K, Najjar SS, Boudreau RM, Venkitachalam L, Kupelian V, Simonsick EM, et al. Health ABC Study (Elevated aortic pulse wave velocity, a marker of arterial stiffness, predicts cardiovascular events in well-functioning older adults). Circulation. 2005;111:3384–3390
  15. Willum-Hansen T, Staessen JA, Torp-Pedersen C, Rasmussen S, Thijs L, Ibsen H, et al. Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation. 2006;113:664–670
  16. Shokawa T, Imazu M, Yamamoto H, Toyofuku M, Tasaki N, Okimoto T, et al. Pulse wave velocity predicts cardiovascular mortality: findings from the Hawaii-Los Angeles-Hiroshima Study. Circ J. 2005;69:259–264
  17. Dernellis J, Panaretou M. Aortic stiffness is an independent predictor of progression to hypertension in nonhypertensive subjects. Hypertension. 2005;45:426–431
  18. van Bortel LM, Duprez D, Starmans-Kool MJ, Safar ME, Giannattasio C, Cockcroft J, et al. Applications of arterial stiffness, task force III: recommendations for user procedures. Am J Hypertens. 2002;15:445–452
  19. Asmar R, Benetos A, Topouchian J, Laurent P, Pannier B, Brisac AM, et al. Assessment of arterial distensibility by automatic pulse wave velocity measurement (Validation and clinical application studies). Hypertension. 1995;26:485–490
  20. Laurent S, Boutouyrie P. Determination of systemic and regional arterial stiffness. In:  Safar ME,  O’Rourke MF editor. Handbook of Hypertension: Arterial Stiffness in Hypertension. New York, New York: Elsevier; 2006;p. 53–62
  21. Asmar R. Pulse wave velocity and therapy. In:  Safar ME editors. Arterial Stiffness and Pulse Wave Velocity: Clinical Applications. Paris, France: Editions Scientifiques et Médicales Elsevier SAS; 1999;p. 143–157
  22. Laurent S, Kingwell B, Bank A, Weber M, Struijker-Boudier H. Clinical applications of arterial stiffness: therapeutics and pharmacology. Am J Hypertens. 2002;15:453–458
  23. Asmar R, Benetos A, London GM, Hugue C, Weiss Y, Topouchian J, et al. Aortic distensibility in normotensive, untreated and treated hypertensive patients. Blood Pressure. 1995;4:48–54
  24. Topouchian J, Asmar R, Sayegh F, Rudnicki A, Benetos A, Bacri AM, et al. Changes in arterial structure and function under trandolapril-verapamil combination in hypertension. Stroke. 1999;30:1056–1064
  25. Asmar RG, Pannier B, Santoni JP, Laurent S, London GM, Levy BI, et al. Reversion of cardiac hypertrophy and reduced arterial compliance after converting enzyme inhibition in essential hypertension. Circulation. 1988;78:941–950
  26. Asmar R, Journo HJ, Lacolley PJ, Santoni JP, Billaud E, Levy BI, et al. Treatment for one year with perindopril: effect on cardiac mass and arterial compliance in essential hypertension. J Hypertens. 1988;6(suppl 3):S33–S39
  27. Kool MJ, Lustermans FA, Breed JG, Struyker-Boudier HA, Hoeks AP, Reneman RS, et al. The influence of perindopril and the diuretic combination amiloride þ hydrochlorothiazide on the vessel wall properties of large arteries in hypertensive patients. J Hypertens. 1995;13:839–848
  28. Asmar R, Benetos A, Darne B, Pauly N, Safar M. Converting enzyme inhibition: dissociation between antihypertensive and arterial effects. J Hum Hypertens. 1992;6:381–385
  29. Asmar R, Iannascoli F, Benetos A, Safar M. Dose optimization study of arterial changes associated with angiotensin converting enzyme inhibition in hypertension. J Hypertens. 1992;10(suppl 5):S13–S19
  30. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G The Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med. 2000;342:145–153
  31. Fox K European Trial on Reduction of Cardiac Events with Perindopril in Stable Coronary Artery Disease Investigators. Efficacy of Perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet. 2003;362:782–788
  32. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood pressure lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet. 2001;358:1033–1041
  33. Sever PS, Dahlof B, Poulter NR, et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomized controlled trial. Lancet. 2003;361:1149–1158
  34. Heart Protection Study Collaborative Group. MRC/BHF heart protection study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomized placebo-controlled trial. Lancet. 2002;360:7–22
  35. Asmar R, Topouchian J, Crisan O, Pannier B, Rudnichi A, Safar M. Reversal of arterial abnormalities by long-term antihypertensive therapy in a large population (The Complior study). J Hypertens. 1999;17(suppl 3):S9
  36. Asmar RG, London GM, O’Rourke ME, Safar ME REASON Project Coordinators, Investigators. Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/indapamide combination in hypertensive patient: a comparison with atenolol. Hypertension. 2001;38:922–926
  37. Therapeutic aspects of arterial stiffness and wave reflections. In:  Safar ME,  O’Rourke MF editor. Handbook of Hypertension — Arterial Stiffness in Hypertension. New York, New York: Elsevier; 2006;p. 459–580
  38. Asmar R, Gosse P, Topouchian J, N’Tela G, Dudley A, Shepherd GL. Effects of telmisartan on arterial stiffness in type 2 diabetes patients with essential hypertension. JRASS. 2002;3:176–180
  39. White WB, Duprez D, St Hilaire R, Krause S, Roniker B, Hamilton JK, et al. Effects of the selective aldosterone blocker eplerenone versus the calcium antagonist amlodipine in systolic hypertension. Hypertension. 2003;42:1021–1026
  40. Rajzer M, Klocek M, Kawecka-Jaszcz K. Effect of amlodipine, quinapril, and losartan on pulse wave velocity and plasma collagen markers in patients with mild-to-moderate arterial hypertension. Am J Hypertens. 2003;16:439–444
  41. Kingwell BA. Statins and arterial stiffness. In:  Safar ME,  O’Rourke MF editor. Handbook of Hypertension — Arterial Stiffness in Hypertension. New York, New York: Elsevier; 2006;p. 559–566
  42. Ichihara A, Hayashi M, Koura Y, Kaneshiro Y, Saruta T. Long-term effects of statins on arterial pressure and stiffness of hypertensives. J Hum Hypertens. 2005;19:103–109
  43. Shinohara K, Shoji T, Kimoto E, Yokoyama H, Fujiwara S, Hatsuda S, et al. Effect of atorvastatin on regional arterial stiffness in patients with type 2 diabetes mellitus. J Atheroscler Thromb. 2005;12:205–210
  44. Guerin AP, Blacher J, Pannier B, Marchais SJ, Safar ME, London GM. Impact of aortic stiffness attenuation on survival of patients in endstage renal failure. Circulation. 2001;103:987–992
  45. Williams B, Lacy PS, Thom SM, Cruickshank K, Stanton A, Collier D, et al. CAFÉ investigators Anglo-Scandinavian Cardiac Outcomes Trial Investigators CAFÉ Steering Committee Writing Committee Differential impact of blood pressure lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Arterty Function Evaluation (CAFÉ) study. Circulation. 2006;113:1213–1225
  46. Shoji T, Emoto M, Shinohara K, Kakiya R, Tsujimoto H, Ishimura E, et al. Diabetes mellitus, aortic stiffness, and cardiovascular mortality in end-stage renal disease. J Am Soc Nephrol. 2001;12:2117–2124

 Conflict of interest: none.

PII: S1933-1711(07)00037-X

doi: 10.1016/j.jash.2007.01.007

Journal of the American Society of Hypertension
Volume 1, Issue 2 , Pages 104-112 , March 2007

Article Tools

* Image Usage & Resolution